Reduktion der postoperativen Endophthalmitisrate durch intrakamerale Cerfuroximgabe: Ergebnisse aus 5 Jahren Erfahrungen an der Universitäts-Augenklinik Tübingen

 

 Buy Article Permissions and Reprints

Zusammenfassung

Hintergrund: Die Kataraktoperation ist die am häufigsten durchgeführte Operation in den Industrieländern. Allein in Deutschland werden jährlich über 600 000 Eingriffe durchgeführt. Die akute postoperative Endophthalmitis ist die schwerwiegendste und am meisten gefürchtete Komplikation bei Kataraktoperationen. Verschiedene operative und nicht operative Maßnahmen wurden vorgeschlagen, um diese ernsthafte Komplikation zu verhindern. Die Studie der European Society of Cataract & Refractive Surgeons (ESCRS) war die erste prospektive, randomisierte und partiell placebokontrollierte Studie, welche die Effektivität der intrakameralen Cefuroximgabe als Endophthalmitisprophylaxe zeigen konnte. Das Ziel dieser retrospektiven Studie war es, eine mögliche Reduktion der postoperativen Endophthalmitisrate durch intrakamerale Cefuroximgabe an der Universitäts-Augenklinik Tübingen zu zeigen. Patienten und Methoden: Im Zeitraum zwischen Januar 2002 und August 2013 wurden 2 Zeitintervalle auf Basis der eingeführten intrakameralen Cefuroximgabe nach der Kataraktoperation bestimmt. Zwischen Januar 2002 und Mai 2009 erhielten Patienten am Ende der Kataraktoperation eine subkonjunktivale Gabe von 50 mg Mezlocillin und anschließend antibiotische Augentropfen (Gentamicin) ohne intrakamerale Injektion. Zwischen Juni 2009 und August 2013 erhielten Patienten eine intrakamerale Injektion mit 1 mg Cefuroxim in 0,1 ml, antibiotische Augentropfen (Moxifloxacin) wurden zusätzlich verwendet. Es wurden die Raten der postoperativen infektiösen Endophthalmitis in diesen beiden Zeitintervallen berechnet. Ergebnisse: Es traten 31 Fälle von postoperativer infektiöser Endophthalmitis bei 31 386 Kataraktoperationen auf. Die Gesamtinzidenz betrug 0,99 pro 1000 Patienten. Die Inzidenz im 1. Zeitintervall ohne intrakamerale Cefuroximgabe betrug 1,38 (95 %-Konfidenzintervall [KI]: 1,03–1,72) pro 1000 Patienten und im 2. Intervall 0,44 (95 %-KI: 0,34–0,54) pro 1000 Patienten (p < 0,001). Schlussfolgerung: Die intrakamerale Cefuroximgabe nach Kataraktoperation reduziert die postoperative infektiöse Endophthalmitisrate signifikant.

Abstract

Background: Cataract surgery is the most commonly performed surgical procedure in developed countries. The annual number of cataract surgeries in Germany is about 600,000. Acute postoperative endophthalmitis is a very severe and the most dreaded complication of cataract surgery. Various operative and non-operative measures have been suggested to prevent this serious complication. The European Society of Cataract & Refractive Surgeons (ESCRS) study of intracameral cefuroxime was the first prospective, randomised and partially placebo-controlled clinical trial showing the efficacy of antibiotic prophylaxis to prevent endophthalmitis in 2007. The aim of this retrospective study is to investigate a possible reduction of intracameral cefuroxime to prevent postoperative endophthalmitis at the University Eye Hospital Tübingen. Patients and Methods: During the period from January 2002 to August 2013, 2 time periods were determined based on the adoption of intracameral cefuroxime injections after cataract surgery. From January 2002 to May 2009 patients received at the end of cataract surgery a subconjunctival administration of 50 mg of mezlocillin and postoperative antibiotic eye drops (gentamicin) without intracameral injection. From June 2009 to August 2013, patients received an intracameral injection of cefuroxime while antibiotic drops (moxifloxacin) were used too. The rates of postoperative infectious endophthalmitis during these 2 periods were calculated. Results: 31 cases of endophthalmitis occurred in 31,386 cataract surgeries. The overall cumulative incidence was 0.99 per 1000 patients. The incidence in the first period without intracameral cefuroxime injection was 1.38 (95 % confidence interval [CI]: 1.03–1.72) per 1000 patients and in the second period 0.44 (95 % CI: 0.34–0.54) per 1000 patients (p < 0.001). Conclusion: Intracameral injection of cefuroxime reduces the rate of postoperative infectious endophthalmitis in cataract surgery significantly.

• Literatur

• 1 Kohnen T, Baumeister M, Kook D et al. Cataract surgery with implantation of an artificial lens. Dtsch Arztebl Int 2009; 106: 695-702
  PubMedGoogle Scholar
• 2 Nanavaty MA, Wearne MJ. Perioperative antibiotic prophylaxis during phaco-emulsification and intraocular lens implantation: national survey of smaller eye units in England. Clin Experiment Ophthalmol 2010; 38: 462-466
  CrossrefPubMedGoogle Scholar
• 3 Yu-Wai-Man P, Morgan SJ, Hildreth AJ et al. Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2008; 34: 447-451
  CrossrefPubMedGoogle Scholar
• 4 Taban M, Behrens A, Newcomb RL et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 2005; 123: 613-620
  CrossrefPubMedGoogle Scholar
• 5 Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 2002; 109: 13-24
  CrossrefPubMedGoogle Scholar
• 6 Lundström M, Wejde G, Stenevi U et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007; 114: 866-870
  CrossrefPubMedGoogle Scholar
• 7 Montan PG, Wejde G, Koranyi G et al. Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2002; 28: 977-981
  CrossrefPubMedGoogle Scholar
• 8 Montan PG, Wejde G, Setterquist H et al. Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 2002; 28: 982-987
  CrossrefPubMedGoogle Scholar
• 9 Wejde G, Samolov B, Seregard S et al. Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study. J Hosp Infect 2005; 61: 251-256
  CrossrefPubMedGoogle Scholar
• 10 Seal DV, Barry P, Gettinby G et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study. J Cataract Refract Surg 2006; 32: 396-406
  CrossrefPubMedGoogle Scholar
• 11 Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007; 33: 978-988
  CrossrefPubMedGoogle Scholar
• 12 Cao H, Zhang L, Li L et al. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS One 2013; 8: e71731
  CrossrefPubMedGoogle Scholar
• 13 Freeman EE, Roy-Gagnon MH, Fortin E et al. Rate of endophthalmitis after cataract surgery in Quebec, Canada, 1996–2005. Arch Ophthalmol 2010; 128: 230-234
  CrossrefPubMedGoogle Scholar
• 14 Li J, Morlet N, Ng JQ et al. Significant nonsurgical risk factors for endophthalmitis after cataract surgery: EPSWA fourth report. Invest Ophthalmol Vis Sci 2004; 45: 1321-1328
  CrossrefPubMedGoogle Scholar
• 15 Tordoff JM, Bagge ML, Gray AR et al. Medicine-taking practices in community-dwelling people aged > or = 75 years in New Zealand. Age Ageing 2010; 39: 574-580
  CrossrefPubMedGoogle Scholar
• 16 Bekibele CO, Kehinde AO, Ajayi BG. Upper lid skin bacterial count of surgical eye patients in Ibadan, Nigeria. Afr J Med Med Sci 2008; 37: 273-277
  PubMedGoogle Scholar
• 17 Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991; 98: 1769-1775
  CrossrefPubMedGoogle Scholar
• 18 Clark A, Morlet N, Ng JQ et al. Whole population trends in complications of cataract surgery over 22 years in Western Australia. Ophthalmology 2011; 118: 1055-1061
  CrossrefPubMedGoogle Scholar
• 19 Ravindran RD, Venkatesh R, Chang DF et al. Incidence of post-cataract endophthalmitis at Aravind Eye Hospital: outcomes of more than 42,000 consecutive cases using standardized sterilization and prophylaxis protocols. J Cataract Refract Surg 2009; 35: 629-636
  CrossrefPubMedGoogle Scholar
• 20 Montan PG, Koranyi G, Setterquist HE et al. Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history: a retrospective case-control study. Ophthalmology 1998; 105: 2171-2177
  CrossrefPubMedGoogle Scholar
• 21 Cooper BA, Holekamp NM, Bohigian G et al. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol 2003; 136: 300-305
  CrossrefPubMedGoogle Scholar
• 22 Bainbridge JW, Teimory M, Tabandeh H et al. Intraocular lens implants and risk of endophthalmitis. Br J Ophthalmol 1998; 82: 1312-1315
  CrossrefPubMedGoogle Scholar
• 23 García-Sáenz MC, Arias-Puente A, Fresnadillo-Martinez MJ et al. In vitro adhesion of Staphylococcus epidermidis to intraocular lenses. J Cataract Refract Surg 2000; 26: 1673-1679
  CrossrefPubMedGoogle Scholar
• 24 Kodjikian L, Burillon C, Chanloy C et al. In vivo study of bacterial adhesion to five types of intraocular lenses. Invest Ophthalmol Vis Sci 2002; 43: 3717-3721
  PubMedGoogle Scholar
• 25 Maylath FR, Leopold IH. Study of experimental intraocular infection. I. The recoverability of organisms inoculated into ocular tissues and fluids. II. The influence of antibiotics and cortisone, alone and combined, on intraocular growth of these organisms. Am J Ophthalmol 1955; 40: 86-101
  CrossrefPubMedGoogle Scholar
• 26 Beyer TL, Vogler G, Sharma D et al. Protective barrier effect of the posterior lens capsule in exogenous bacterial endophthalmitis–an experimental primate study. Invest Ophthalmol Vis Sci 1984; 25: 108-112
  PubMedGoogle Scholar
• 27 Beyer TL, OʼDonnell FE, Goncalves V et al. Role of the posterior capsule in the prevention of postoperative bacterial endophthalmitis: experimental primate studies and clinical implications. Br J Ophthalmol 1985; 69: 841-846
  CrossrefPubMedGoogle Scholar
• 28 Pleyer U, Geldsetzer K. [Will intracameral cefuroxime become the new standard in endophthalmitis prevention?]. Klin Monatsbl Augenheilkd 2008; 225: 934-940
  Article in Thieme ConnectPubMedGoogle Scholar
• 29 Arzneistoffe von A–Z, Alles zu Wirkstoffen, Wirkungsmechanismus der Cephalosporine. Im Internet: http://www.arzneistoffe.net/Wirkungsmechanismus%20der%20Cephalosporine.html Stand: 22.04.2014
  PubMedGoogle Scholar
• 30 Jensen MK, Fiscella RG, Moshirfar M et al. Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg 2008; 34: 1460-1467
  CrossrefPubMedGoogle Scholar
• 31 Romano A, Mayorga C, Torres MJ et al. Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol 2000; 106: 1177-1183
  CrossrefPubMedGoogle Scholar
• 32 Romano A, Guéant-Rodriguez RM, Viola M et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004; 141: 16-22
  CrossrefPubMedGoogle Scholar
• 33 Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345: 804-809
  CrossrefPubMedGoogle Scholar
• 34 Annè S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74: 167-170
  PubMedGoogle Scholar